Related Experiment Video
Updated: Aug 5, 2026

07:49
Colonial Wig Pancreaticojejunostomy
Published on: March 12, 2019
Biliopancreatic diversion in Poland
1Department of General and Bariatric Surgery, Zabrze, Medical University of Silesia, Katowice, Poland. wylezol@mp.pl
Summary
Biliopancreatic diversion (BPD) effectively reduces weight and improves metabolic health in Polish patients. This bariatric surgery significantly resolves type 2 diabetes and normalizes lipid levels, demonstrating its efficacy in this population.
Area of Science:
- Bariatric Surgery
- Metabolic Surgery
- Surgical Gastroenterology
Background:
- Biliopancreatic diversion (BPD) is a bariatric procedure known for its effectiveness, particularly in managing metabolic comorbidities.
- Obesity and associated metabolic disturbances are significant health concerns in the Polish population.
Purpose of the Study:
- To evaluate the efficacy of Biliopancreatic diversion (BPD) in the Polish population.
- To assess BPD's impact on weight loss, and disturbances in lipid and glucose metabolism.
Main Methods:
- A cohort of 57 morbidly obese patients (BMI 50.2 kg/m²) underwent BPD between October 2001 and December 2003.
- Patients with type 2 diabetes (19.3%), hypercholesterolemia (66.7%), and hypertriglyceridemia (64.9%) were included.
- Outcomes including weight loss, metabolic parameters, and complications were monitored.
Main Results:
- Significant weight loss was observed, with median BMI decreasing from 50.2 kg/m² pre-operatively to 32.3 kg/m² after one year.
- Type 2 diabetes resolved completely in all affected patients.
- Lipid profiles improved significantly, with only one patient showing elevated triglycerides and cholesterol after six months.
Conclusions:
- Biliopancreatic diversion (BPD) is a highly effective bariatric procedure in the Polish population.
- BPD leads to substantial weight reduction and significant improvements in both lipid and glucose metabolism.
- While complications exist, they are generally manageable, supporting BPD as a viable option for severe obesity and metabolic disorders.

